Bladder cancer outcomes reviewed

Printer-friendly version Printer Friendly Version
Email Story Send This Story

July 2010
In the largest study to date of a rare and deadly form of bladder cancer, researchers at Henry Ford Hospital in Detroit found radiation therapy may not improve a patient's chances for survival.

While overall survival for adenocarcinoma of the bladder was poor, the study revealed several factors that may improve a patient's prognosis, including being diagnosed at age 60 or younger, and having cystectomy, a procedure that either removes all or a portion of the bladder.

"While this malignancy afflicts just one to 2% of people diagnosed with bladder cancer, chances of surviving it for five years are grim – only 18% – in part because it is usually detected at an advanced stage," said study lead author Naveen Pokala, M.D., an urologist at Henry Ford Hospital. "By the time the primary cancer is found, it may already have penetrated all four walls of the bladder and spread to adjacent organs and beyond, including the peritoneum, lymph nodes, and lungs."


Printer-friendly version Printer Friendly Version
Email Story Send This Story
Supplier Search
Story Search

FEATURE ARTICLE

Guide to insulin pump therapy
The NHS Technology Adoption Centre aims to encourage the increased use of continuous subcutaneous insulin infusion (CSII), also known as insulin pump therapy, to improve the management of Type 1 diabetes, in line with NICE guidance. HADLEIGH STOLLAR, programme manager, the NHS Technology Adoption Centre, explains how the latest “How to, Why to” guide can support Trusts in managing implementation.

PRODUCT ARTICLE

Fully virucidal alcohol hand gel
ECOLAB, an infection prevention specialist, will be showcasing its new fully virucidal alcohol hand gel, Spirigel Complete. With the theme of “Complete Protection – Everywhere It Matters”, the company will be demonstrating its products and services to the attending delegates.